News Room

Alzheimer's disease, Investor Announcement

IMAGINE Phase 2 clinical trial Investor Conference call

MELBOURNE, March 31, 2013: Access to the IMAGINE Phase 2 clinical trial investor conference call hosted on Monday 31st March Australian EDT is available via Open Briefing.

It can also be heard here. IMAGINE results Conference Call